CoVPN 3001 A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Fred Hutchinson Cancer Center
Start Date
April 1, 2022
End Date
November 30, 2023
Administered By
Surgery, Surgical Sciences
Awarded By
Fred Hutchinson Cancer Center
Start Date
April 1, 2022
End Date
November 30, 2023